Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-18,000
Closed -$672K 856
2018
Q1
$672K Hold
18,000
0.01% 616
2017
Q4
$770K Hold
18,000
0.01% 601
2017
Q3
$660K Sell
18,000
-41,400
-70% -$1.67M 0.01% 575
2017
Q2
$2.7M Buy
59,400
+18,800
+46% +$830K 0.08% 235
2017
Q1
$1.73M Buy
40,600
+19,300
+91% +$787K 0.02% 624
2016
Q4
$855K Sell
21,300
-15,500
-42% -$598K 0.02% 484
2016
Q3
$1.43M Sell
36,800
-50,200
-58% -$1.9M 0.04% 359
2016
Q2
$3.01M Hold
87,000
0.08% 189
2016
Q1
$3M Buy
87,000
+52,400
+151% +$1.83M 0.08% 188
2015
Q4
$1.34M Sell
34,600
-19,400
-36% -$755K 0.03% 405
2015
Q3
$2.11M Buy
54,000
+15,500
+40% +$615K 0.05% 279
2015
Q2
$1.47M Buy
38,500
+22,400
+139% +$784K 0.04% 392
2015
Q1
$532K Hold
16,100
0.01% 673
2014
Q4
$431K Sell
16,100
-33,300
-67% -$860K 0.01% 706
2014
Q3
$1.2M Buy
49,400
+24,600
+99% +$621K 0.03% 419
2014
Q2
$629K Buy
24,800
+12,300
+98% +$287K 0.02% 637
2014
Q1
$269K Buy
+12,500
New +$270K 0.01% 817

Other funds holding HOLX

Barings's HOLX Position: Q2 2018 in Review

Barings sold out of Hologic (HOLX) in Q2 2018, closing a stake of 18,000 shares — an estimated $672K sold.

Barings first reported a position in HOLX in Q1 2014 and held it in 17 quarters. The position peaked at $3.01M in Q2 2016. 449 funds tracked by Wall St. Rank hold HOLX as of Q2 2018.

  • Barings reported no remaining Hologic position as of Q2 2018 after selling out during the quarter.
  • Barings sold 18,000 Hologic shares in Q2 2018, an estimated $672K.
  • Barings first reported a position in Hologic in Q1 2014 and held it in 17 quarters.
  • Barings's Hologic position peaked at $3.01M in Q2 2016.
  • 449 funds tracked by Wall St. Rank held Hologic as of Q2 2018.

Based on Barings's 13F filing for Q2 2018, filed 3 Aug 2018.